Glrx3 | glutaredoxin 3
Physiological systems
19 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Mortality/aging
17 No significant impact
5 Not tested
Data collections
Gene metrics:4Significant phenotypes
0Associated diseases
Expression examined in:48Adult tissues
25Embryo tissues
increased circulating alkaline phosphatase level | 1 supporting dataset | Glrx3tm1.1(KOMP)Vlcg | heterozygote | Early adult | 2.42x10-5 | ||
embryonic lethality prior to tooth bud stage | 1 supporting dataset | Glrx3tm1.1(KOMP)Vlcg | homozygote | E12.5 | N/A * | ||
preweaning lethality, complete penetrance | 1 supporting dataset | Glrx3tm1.1(KOMP)Vlcg | homozygote | Early adult | N/A * | ||
embryonic lethality prior to organogenesis | 1 supporting dataset | Glrx3tm1.1(KOMP)Vlcg | homozygote | E9.5 | N/A * |
| | | | | | | | | |
External links
No external links available for Glrx3.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Glrx3tm1(KOMP)Vlcg | Reporter-tagged deletion allele (with selection cassette) | | ES Cell mouse |
Glrx3tm1.1(KOMP)Vlcg | Reporter-tagged deletion allele (post Cre, with no selection cassette) | | mouse |
Glrx3tm383784(L1L2_Bact_P) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |